DVAX [NASD]
Dynavax Technologies Corporation
Index- P/E18.50 EPS (ttm)0.52 Insider Own0.20% Shs Outstand124.56M Perf Week29.13%
Market Cap1.00B Forward P/E14.40 EPS next Y0.67 Insider Trans-45.84% Shs Float111.24M Perf Month-6.05%
Income104.10M PEG- EPS next Q0.22 Inst Own78.90% Short Float15.85% Perf Quarter-26.23%
Sales470.10M P/S2.13 EPS this Y172.60% Inst Trans2.81% Short Ratio6.92 Perf Half Y-43.94%
Book/sh2.31 P/B4.16 EPS next Y-41.56% ROA11.50% Target Price26.25 Perf Year25.75%
Cash/sh4.83 P/C1.99 EPS next 5Y- ROE63.00% 52W Range7.26 - 21.39 Perf YTD-31.63%
Dividend- P/FCF4.21 EPS past 5Y16.90% ROI29.00% 52W High-55.03% Beta1.46
Dividend %- Quick Ratio1.80 Sales past 5Y108.90% Gross Margin59.80% 52W Low32.51% ATR0.77
Employees311 Current Ratio2.00 Sales Q/Q36.90% Oper. Margin28.00% RSI (14)51.56 Volatility9.92% 8.37%
OptionableYes Debt/Eq0.77 EPS Q/Q- Profit Margin22.10% Rel Volume1.81 Prev Close9.73
ShortableNo LT Debt/Eq0.77 EarningsMay 05 AMC Payout0.00% Avg Volume2.55M Price9.62
Recom1.70 SMA205.36% SMA50-5.01% SMA200-30.25% Volume4,536,385 Change-1.13%
Jan-06-22Resumed Goldman Buy $38
Aug-06-21Initiated Goldman Buy $19
Aug-07-20Reiterated H.C. Wainwright Buy $14 → $12
Aug-03-20Reiterated H.C. Wainwright Buy $12 → $14
Jun-15-20Initiated Evercore ISI Outperform $14
Oct-18-19Initiated H.C. Wainwright Buy $13
Jul-11-19Upgrade Cantor Fitzgerald Neutral → Overweight $20
Feb-27-19Reiterated Cantor Fitzgerald Overweight $32 → $28
May-10-18Upgrade JP Morgan Neutral → Overweight
Mar-08-18Reiterated Cantor Fitzgerald Overweight $25 → $27
Feb-14-18Downgrade JP Morgan Overweight → Neutral
Sep-25-17Reiterated RBC Capital Mkts Outperform $26 → $28
Sep-15-17Initiated Cantor Fitzgerald Overweight $24
Jul-31-17Upgrade RBC Capital Mkts Sector Perform → Outperform $7 → $26
Jul-31-17Upgrade JP Morgan Neutral → Overweight
May-09-17Reiterated RBC Capital Mkts Sector Perform $6 → $7
Apr-28-16Downgrade RBC Capital Mkts Outperform → Sector Perform $48 → $17
Apr-27-16Downgrade JP Morgan Overweight → Neutral
Nov-30-15Initiated RBC Capital Mkts Outperform $48
Nov-25-13Upgrade MLV & Co Hold → Buy $1.50 → $5
May-16-22 06:46PM  
04:10PM  
May-13-22 04:17PM  
May-12-22 06:16PM  
May-08-22 07:31AM  
May-06-22 09:01AM  
May-05-22 06:05PM  
04:02PM  
12:08PM  
07:00AM  
May-04-22 02:25PM  
May-03-22 07:20AM  
Apr-21-22 04:05PM  
Apr-05-22 04:02PM  
Apr-03-22 02:55PM  
Mar-18-22 09:20AM  
Mar-17-22 10:51AM  
10:45AM  
07:00AM  
Mar-08-22 04:05PM  
Mar-03-22 04:05PM  
Mar-01-22 07:08PM  
11:59AM  
11:19AM  
Feb-28-22 08:30PM  
06:05PM  
04:02PM  
Feb-26-22 06:45AM  
Feb-25-22 11:15AM  
Feb-24-22 09:05AM  
06:00AM  
Feb-23-22 04:05PM  
Feb-20-22 02:27AM  
Feb-17-22 03:02PM  
08:25AM  
Feb-16-22 04:05PM  
Feb-15-22 12:40PM  
10:14AM  
Feb-03-22 12:06PM  
Feb-02-22 04:05PM  
04:14AM  
Feb-01-22 08:44AM  
Jan-27-22 12:16PM  
Jan-21-22 05:28AM  
Jan-19-22 12:53PM  
06:00AM  
Jan-10-22 08:00AM  
Jan-07-22 04:05PM  
Jan-05-22 04:05PM  
Dec-31-21 06:15PM  
09:40AM  
Dec-29-21 05:55PM  
Dec-28-21 01:54PM  
11:34AM  
Dec-23-21 08:09AM  
Dec-14-21 08:10AM  
Dec-05-21 08:39AM  
Dec-03-21 04:15PM  
11:34AM  
Dec-02-21 04:05PM  
Nov-18-21 04:10PM  
Nov-12-21 07:54AM  
Nov-10-21 12:22PM  
Nov-05-21 12:16PM  
12:01PM  
Nov-04-21 06:35PM  
04:02PM  
Nov-02-21 04:10PM  
Oct-30-21 10:04AM  
Oct-29-21 08:01AM  
Oct-28-21 03:06PM  
Oct-27-21 01:46PM  
06:36AM  
Oct-21-21 04:20PM  
08:00AM  
Oct-18-21 05:43PM  
01:49PM  
02:27AM  
Oct-06-21 11:31AM  
Oct-05-21 09:17AM  
Oct-04-21 08:00AM  
Oct-01-21 06:13PM  
11:27AM  
Sep-27-21 04:15PM  
11:39AM  
Sep-25-21 05:55AM  
Sep-24-21 03:45AM  
Sep-23-21 10:34AM  
Sep-22-21 12:42PM  
09:36AM  
07:05AM  
Sep-18-21 07:03AM  
Sep-16-21 04:31PM  
Sep-15-21 07:27AM  
Sep-13-21 11:22AM  
10:09AM  
08:32AM  
02:30AM  
Sep-09-21 04:02PM  
Sep-07-21 10:05AM  
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Burgess JustinPrincipal Accounting OfficerMay 17Sale10.006,00060,0003,854May 18 06:16 PM
Novack David FPresident & COOMar 03Sale10.5741,862442,48173,213Mar 04 09:18 PM
Spencer RyanCEO and DirectorMar 03Sale10.5683,108877,923129,771Mar 04 08:16 PM
Burgess JustinPrincipal Accounting OfficerMar 03Sale10.5821,490227,3643,854Mar 04 08:03 PM
Janssen RobertSenior Vice PresidentMar 03Sale10.5724,036253,99824,707Mar 04 08:04 PM
Spencer RyanCEO and DirectorFeb 10Option Exercise0.0089,2500160,839Feb 14 09:09 PM
Janssen RobertSenior Vice PresidentNov 17Option Exercise10.4753,431559,42361,707Nov 18 05:06 PM
Janssen RobertSenior Vice PresidentNov 17Sale17.0753,431912,2928,276Nov 18 05:06 PM
Janssen RobertSenior Vice PresidentNov 16Option Exercise10.4735,974376,64844,250Nov 18 05:06 PM
Janssen RobertSenior Vice PresidentNov 16Sale17.1635,974617,4798,276Nov 18 05:06 PM
Novack David FPresident & COONov 01Sale20.1220,000402,40044,066Nov 02 05:30 PM
Novack David FPresident & COOOct 07Sale18.003,00054,00064,066Oct 08 05:59 PM
Novack David FPresident & COOOct 01Sale18.2317,000309,84467,066Oct 05 07:04 PM
Janssen RobertSenior Vice PresidentSep 01Option Exercise10.479009,4239,176Sep 03 05:00 PM
Burgess JustinPrincipal Accounting OfficerSep 01Option Exercise3.8120,00076,20023,721Sep 03 05:00 PM
Janssen RobertSenior Vice PresidentSep 01Sale20.1590018,1358,276Sep 03 05:00 PM
Novack David FPresident & COOSep 01Sale19.9920,000399,77084,066Sep 03 05:00 PM
Burgess JustinPrincipal Accounting OfficerSep 01Sale20.0020,000400,0003,721Sep 03 05:00 PM
Hack Andrew A. F.DirectorAug 27Sale16.222,000,00032,440,0008,415,000Aug 27 08:07 PM
CANO FRANCISDirectorAug 24Option Exercise4.504,16718,75220,834Aug 25 07:32 PM
Burgess JustinPrincipal Accounting OfficerAug 24Sale15.005,76886,5203,721Aug 25 07:32 PM
Novack David FPresident & COOAug 24Sale14.0010,000140,000104,066Aug 25 07:35 PM
Novack David FPresident & COOAug 23Option Exercise4.504,16718,752114,066Aug 25 07:35 PM
Phillips Peggy VDirectorAug 23Option Exercise4.504,16618,74727,733Aug 25 07:33 PM
Janssen RobertSenior Vice PresidentAug 16Option Exercise5.422,91715,81011,193Aug 18 07:11 PM
Janssen RobertSenior Vice PresidentAug 16Sale12.362,91736,0548,276Aug 18 07:11 PM
Janssen RobertSenior Vice PresidentAug 11Option Exercise5.4249,583268,74056,444Aug 13 06:58 PM
Novack David FPresident & COOAug 11Sale12.0010,000120,000107,399Aug 13 06:59 PM
Janssen RobertSenior Vice PresidentAug 11Sale12.0649,583597,9716,861Aug 13 06:58 PM
Hack Andrew A. F.DirectorAug 09Sale10.802,250,00024,300,0008,524,000Aug 11 06:26 PM
Janssen RobertSenior Vice PresidentAug 06Sale10.7580,000860,0006,861Aug 10 06:57 PM